Consensus Crossject

Stocks

ALCJ

FR0011716265

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 19:55:00 30/06/2026 +04			After hours 20:24:45
1.784 ^EUR	-3.25%		1.785	+0.06%

05-26	Crossject: The last round of financing?	AL
05-25	Crossject buoyed by Oddo BHF note following capital hike

Evolution of the Average Target: Crossject

Evolution of the Target Price: Crossject

Changes in Analyst Recommendations: Crossject

9c41f4a86c0575a6d.cE_gF_ERPoszukWXzMmSg2FrLBhHepPjZfbNhqUhWmg.KiqSWYV3cvge-TDcpp_3-ic0el8KC6eCJLS_9et3al1GOYZhnntqzmqCfQ~6fa011253377308b8df3749db88869a8

Analysts' recommendations: Crossject

05-26	Crossject: The last round of financing?	AL
03-30	Crossject: Integrating the FY25 numbers	AL
03-25	Crossject: FY25 results: no big change.	AL
11-17	Crossject: Yet another round of financing	AL
25/06/25	Crossject: Invest Securities Upgrades to 'Buy' Following Successful Capital Increase
09/06/25	Crossject: Here we are for the announced capital increase	AL
21/05/25	Crossject: Another capital increase in the pipe…	AL
07/05/25	Crossject: Back to life?	AL
30/03/25	Crossject: Integrating the FY24 numbers.	AL
27/03/25	Crossject: FY24 and outlook: long is the road…	AL
10/02/25	Crossject: A complex financing given the amounts involved	AL
11/12/24	Crossject: An unsurprising additional financing round.	AL
07/10/24	Crossject: H1 24: not yet meaningful	AL
25/09/24	Crossject: H1 24: no real surprise, but a glimpse of disappointment	AL
17/07/24	Crossject: We are still believers	AL
05/06/24	Crossject: Success of the capital increase	AL
02/05/24	Crossject: We welcome the securing of the group’s financial needs	AL
03/04/24	Crossject: Patience is a virtue… hopefully	AL
28/02/24	Crossject: Invest Securities slightly reduces its target
28/02/24	Crossject: Securing the financing needs	AL
08/02/24	Crossject: No news is not always good news...	AL
06/01/24	CROSSJECT : Marketing initiative in the US	AL
03/01/24	CROSSJECT : A new distribution agreement in Northern Europe	AL
28/09/23	CROSSJECT : H1 23: no surprises before the release of the detailed accounts in October	AL
27/03/23	CROSSJECT : No real news in the FY22 results.	AL